Scleroderma, Diffuse: Clinical Trials

1 trial for Scleroderma, Diffuse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Unknown 1

Follow Scleroderma, Diffuse: new trials by email Literature Review of Scleroderma, Diffuse trials Research Report on Scleroderma, Diffuse

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma
Assigned Interventions CD19/BCMA CAR T-cells - Scleroderma, Autoimmune Diseases
Early Phase 1UnknownZhejiang University92021-10-082021-10-20

Narrower conditions

Autoimmune Diseases (1)

Broader conditions

Connective Tissue Diseases (1)  ·  Immune System Diseases (1)  ·  Scleroderma, Systemic (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Sponsors

Zhejiang University (1)

Countries

China (1)

Top investigators

He Huang, PhD (1)